Anchor Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.92M Sell
91,404
-751
-0.8% -$71.9K 0.66% 36
2025
Q4
$8.85M Sell
92,155
-16,418
-15% -$1.59M 0.72% 27
2025
Q3
$10.3M Sell
108,573
-902
-0.8% -$82.9K 0.86% 26
2025
Q2
$9.54M Buy
109,475
+2,479
+2% +$210K 0.84% 27
2025
Q1
$9.61M Buy
106,996
+112
+0.1% +$10K 0.9% 26
2024
Q4
$8.54M Sell
106,884
-634
-0.6% -$54.9K 0.8% 29
2024
Q3
$9.68M Buy
107,518
+1,271
+1% +$107K 0.91% 24
2024
Q2
$8.36M Buy
106,247
+24,936
+31% +$2.04M 0.86% 28
2024
Q1
$7.09M Sell
81,311
-1,378
-2% -$118K 0.74% 33
2023
Q4
$6.81M Buy
82,689
+11,719
+17% +$893K 0.78% 32
2023
Q3
$5.56M Buy
70,970
+10,109
+17% +$846K 0.73% 34
2023
Q2
$5.36M Buy
60,861
+4,855
+9% +$418K 0.68% 37
2023
Q1
$4.52M Buy
56,006
+5,558
+11% +$453K 0.61% 44
2022
Q4
$3.92M Buy
50,448
+3,930
+8% +$319K 0.56% 49
2022
Q3
$3.76M Buy
46,518
+1,296
+3% +$116K 0.58% 46
2022
Q2
$4.06M Buy
45,222
+817
+2% +$82.8K 0.59% 47
2022
Q1
$4.93M Buy
44,405
+2,977
+7% +$315K 0.62% 44
2021
Q4
$4.29M Buy
41,428
+673
+2% +$77.9K 0.53% 52
2021
Q3
$5.11M Buy
40,755
+402
+1% +$52K 0.71% 36
2021
Q2
$5.01M Buy
40,353
+2,032
+5% +$255K 0.69% 35
2021
Q1
$4.53M Buy
38,321
+2,022
+6% +$237K 0.69% 37
2020
Q4
$4.25M Buy
36,299
+1,735
+5% +$191K 0.76% 34
2020
Q3
$3.59M Buy
34,564
+1,145
+3% +$115K 0.73% 38
2020
Q2
$3.06M Buy
33,419
+2,356
+8% +$226K 0.69% 40
2020
Q1
$2.8M Buy
31,063
+560
+2% +$59.6K 0.72% 38
2019
Q4
$3.46M Buy
30,503
+2,440
+9% +$268K 0.74% 34
2019
Q3
$3.05M Buy
28,063
+388
+1% +$40.5K 0.7% 35
2019
Q2
$2.7M Buy
27,675
+2,875
+12% +$262K 0.64% 41
2019
Q1
$2.26M Buy
24,800
+273
+1% +$24.4K 0.56% 47
2018
Q4
$2.23M Buy
24,527
+615
+3% +$57.5K 0.64% 44
2018
Q3
$2.35M Sell
23,912
-1,115
-4% -$103K 0.54% 49
2018
Q2
$2.14M Sell
25,027
-242
-1% -$20.2K 0.53% 50
2018
Q1
$2.03M Buy
25,269
+111
+0.4% +$9.16K 0.53% 52
2017
Q4
$2.03M Buy
25,158
+1,019
+4% +$81.6K 0.54% 54
2017
Q3
$1.88M Buy
24,139
+1,643
+7% +$136K 0.55% 54
2017
Q2
$2M Buy
22,496
+49
+0.2% +$4.13K 0.66% 48
2017
Q1
$1.81M Buy
22,447
+1,795
+9% +$140K 0.62% 48
2016
Q4
$1.47M Hold
20,652
0.55% 54
2016
Q3
$1.78M Sell
20,652
-440
-2% -$38.3K 0.69% 37
2016
Q2
$1.83M Sell
21,092
-936
-4% -$75.7K 0.72% 35
2016
Q1
$1.65M Buy
+22,028
New +$1.66M 0.68% 40

Other funds holding MDT

Anchor Investment Management's MDT Position: Q1 2026 in Review

Anchor Investment Management reduced its Medtronic (MDT) stake by 0.81% in Q1 2026, selling an estimated $71.9K and leaving 91,404 shares worth $7.92M. The position accounts for 0.66% of the portfolio, ranked #36.

Anchor Investment Management first reported a position in MDT in Q1 2016 and has held it in 41 quarters since. The position peaked at $10.3M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Anchor Investment Management held 91,404 shares of Medtronic worth $7.92M as of Q1 2026.
  • Anchor Investment Management sold 751 Medtronic shares in Q1 2026, an estimated $71.9K.
  • Medtronic made up 0.66% of Anchor Investment Management's portfolio in Q1 2026, its #36 holding.
  • Anchor Investment Management first reported a position in Medtronic in Q1 2016 and has held it in 41 quarters since.
  • Anchor Investment Management's Medtronic position peaked at $10.3M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.